Strata Critical Medical, Inc. Cash Flow-to-Debt Ratio
Strata Critical Medical, Inc. cash flow-to-debt ratio. Strata Critical Medical, Inc. (SRTA) has a Cash Flow-to-Debt Ratio of 0.08x as of March 2026, meaning its operating cash flow of $3.56 Million could theoretically repay 0% of its total liabilities ($41.89 Million) in one year. Check SRTA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Strata Critical Medical, Inc. (2019–2025)
Cash flow-to-debt ratio of Strata Critical Medical, Inc. from 2019 to 2025. Historical debt coverage capacity for Strata Critical Medical, Inc. across 7 annual periods. Check SRTA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Strata Critical Medical, Inc. Cash Flow-to-Debt Ratio by Year (2019–2025)
Strata Critical Medical, Inc. cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Strata Critical Medical, Inc.. For the full cash flow conversion analysis, see SRTA operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.05x | $-48.91 Million | $46.40 Million | ▼ -1353.7% |
| 2024 | -0.07x | $-2.52 Million | $34.74 Million | ▲ +86.4% |
| 2023 | -0.53x | $-32.35 Million | $60.64 Million | ▲ +27.4% |
| 2022 | -0.73x | $-37.13 Million | $50.54 Million | ▼ -109.4% |
| 2021 | -0.35x | $-15.62 Million | $44.51 Million | ▲ +78.5% |
| 2020 | -1.63x | $-10.82 Million | $6.63 Million | ▼ -4215.8% |
| 2019 | -0.04x | $-10.30 Million | $272.69 Million | — |